**ACTAVIS LABS FL INC** has announced that the FDA has approved **[Substance]** under ANDA **202144**. The approval is expected to immediately bolster the company’s presence in the market, providing a key generic alternative to **[Substance]**.
**ACTAVIS LABS FL INC** has announced that the FDA has approved **[Substance]** under ANDA **202144**. The approval is expected to immediately bolster the company’s presence in the market, providing a key generic alternative to **[Substance]**.